AKT1 and central nervous system cancer: Ji et al. [28] Han et al. [29] also showed that METTL3 exerts a regulatory function in glioma cell proliferation, migration, and invasion by inhibiting the PI3K/AKT signaling pathway, suggesting that this pathway is a potential therapeutic target for glioma treatment.